We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

129 hedge funds and large institutions have $1.02B invested in Ironwood Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 129 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

348% more call options, than puts

Call options by funds: $11.9M | Put options by funds: $2.66M

Holders
129
Holders Change
+129
Holders Change %
–
% of All Funds
4.21%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
129
Increased
–
Reduced
–
Closed
–
Calls
$11.9M
Puts
$2.66M
Net Calls
+$9.27M
Net Calls Change
+$9.27M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$146M +$213M +17,540,520 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$131M +$191M +15,758,634 New
Morgan Stanley
3
Morgan Stanley
New York
$96.5M +$141M +11,605,930 New
BI
4
BVF Inc
California
$52.3M +$76M +6,271,558 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$51.3M +$74.6M +6,152,619 New
SAM
6
Sectoral Asset Management
Quebec, Canada
$50.5M +$73.7M +6,077,516 New
JHIU
7
Janus Henderson Investors US
Colorado
$45.7M +$66.4M +5,481,176 New
State of Wisconsin Investment Board
8
State of Wisconsin Investment Board
Wisconsin
$43.8M +$63.7M +5,253,576 New
BFA
9
BlackRock Fund Advisors
California
$33.9M +$49.4M +4,072,539 New
WRF
10
Waddell & Reed Financial
Kansas
$32.6M +$47.4M +3,907,420 New
State Street
11
State Street
Massachusetts
$29.9M +$43.4M +3,583,620 New
Capital World Investors
12
Capital World Investors
California
$29.1M +$42.3M +3,492,450 New
BIT
13
BlackRock Institutional Trust
California
$24.9M +$36.4M +2,999,260 New
CGT
14
Capital Guardian Trust
California
$23.2M +$33.7M +2,781,558 New
VM
15
VHCP Management
New York
$17.9M +$26M +2,149,200 New
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$16.8M +$24.5M +2,018,948 New
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$16M +$23.3M +1,924,847 New
TG
18
TCW Group
California
$15.4M +$22.4M +1,844,311 New
Northern Trust
19
Northern Trust
Illinois
$12.3M +$17.9M +1,475,782 New
OIM
20
Oracle Investment Management
Connecticut
$11M +$16M +1,321,856 New
BBA
21
Baker Bros. Advisors
New York
$9.16M +$13.3M +1,101,059 New
RNS
22
Robert N. Shapiro
$8.35M +$12.2M +1,004,051 New
Fidelity International
23
Fidelity International
Bermuda
$8.21M +$12M +987,157 New
TCM
24
Tekla Capital Management
Massachusetts
$7.64M +$11.1M +917,052 New
FIG
25
Fortress Investment Group
New York
$5.1M +$7.42M +612,383 New
1
2 3 4 5

IRWD Hedge Fund Activity: Q2 2013 in Review

129 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q2 2013, worth a combined $1.02B.

Buyers outnumbered sellers: 129 funds opened new IRWD positions and 0 closed out — a net gain of 129 holders — while 0 added to existing stakes and 0 trimmed.

  • 129 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.02B of Ironwood Pharmaceuticals stock for Q2 2013.
  • 129 funds opened new Ironwood Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +129 holders.

Based on aggregated 13F filings for Q2 2013.